| Date Filed | Type | Description |
| 10/02/2023 |
4
| LAPPE RODNEY W (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Bought 21,000 shares
@ $2.347, valued at
$49.3k
|
|
| 06/02/2023 |
4
| George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
| 06/02/2023 |
4
| Prasad Deepa (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
| 06/02/2023 |
4
| Schmid John P. (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
| 06/02/2023 |
4
| Xu Stella (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
| 06/02/2023 |
4
| William Arsani (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
| 06/02/2023 |
4
| Berger Heather A. (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
| 06/02/2023 |
4
| LAPPE RODNEY W (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Prasad Deepa (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $13.69, valued at
$205.4k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
4
| William Arsani (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $18.9872, valued at
$474.7k
|
|
| 03/22/2022 |
4
| Xu Stella (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Sold 552,225 shares
@ $19.04, valued at
$10.5M
Sold 13,200 shares
@ $20.34, valued at
$268.5k
Sold 24,000 shares
@ $19.01, valued at
$456.2k
Sold 1,455 shares
@ $18.6292, valued at
$27.1k
|
|
| 03/18/2022 |
4
| Prasad Deepa (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Acquired 11,806 shares
@ $0 |
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2021 |
4
| Burgess Julie (Chief Accounting Officer) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $14.99, valued at
$2M
|
|
| 09/20/2021 |
3
| Burgess Julie (Chief Accounting Officer) has filed a Form 3 on Design Therapeutics, Inc. |
| 09/02/2021 |
4
| William Arsani (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Bought 40,000 shares
@ $15.45, valued at
$618k
|
|
| 08/17/2021 |
3
| Giangiulio Dawn (Principal Accounting Officer) has filed a Form 3 on Design Therapeutics, Inc. |
|